Credit Suisse Downgrades PDL BioPharma (PDLI) to Underperform

January 15, 2013 8:26 AM EST Send to a Friend
Get Alerts PDLI Hot Sheet
Price: $7.90 +2.60%

Rating Summary:
    1 Buy, 4 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 21 | Down: 43 | New: 52
Trade PDLI Now!
Join SI Premium – FREE
Credit Suisse downgraded PDL BioPharma (NASDAQ: PDLI) from Neutral to Underperform.

For an analyst ratings summary and ratings history on PDL BioPharma click here. For more ratings news on PDL BioPharma click here.

Shares of PDL BioPharma closed at $7.42 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Credit Suisse

Add Your Comment